Literature DB >> 16356835

Tp53-gene transfer induces hypersensitivity to low doses of X-rays in glioblastoma cells: a strategy to convert a radio-resistant phenotype into a radiosensitive one.

Paola D'Avenia1, Alessandro Porrello, Marco Berardo, Marco D' Angelo, Silvia Soddu, Giorgio Arcangeli, Ada Sacchi, Gabriella D'Orazi.   

Abstract

Tp53 is frequently mutated or inactivated in glioblastomas. Due to the impairment of p53 activity, glioblastomas show a high degree of radioresistance. In an attempt to convert the radioresistant phenotype to a more radiosensitive one, we evaluated the efficacy of the combination of Adp53 gene transfer and X-ray irradiation. The combination of Adp53, at low multiplicity in order to mimic the low in vivo efficiency of virus-mediated gene delivery, with X-ray irradiation resulted in a marked decrease of glioblastoms cell survival. Interestingly, Adp53 was able to induce low dose (<2Gy) hypersensitivity. The data suggest the possibility for the development of new therapeutic strategies.

Entities:  

Mesh:

Year:  2006        PMID: 16356835     DOI: 10.1016/j.canlet.2005.01.033

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

1.  Adenovirus-mediated p53 gene transfer sensitizes hepatocellular carcinoma cells to heavy-ion radiation.

Authors:  Bing Liu; Hong Zhang; Guangming Zhou; Yi Xie; Jifang Hao; Rong Qiu; Xin Duan; Qingming Zhou
Journal:  J Gastroenterol       Date:  2007-03-12       Impact factor: 7.527

2.  Low dose hyper-radiosensitivity in human lung cancer cell line A549 and its possible mechanisms.

Authors:  Xiaofang Dai; Dan Tao; Hongge Wu; Jing Cheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

3.  Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study.

Authors:  Mario Balducci; Silvia Chiesa; Barbara Diletto; Giuseppe Roberto D'Agostino; Annunziato Mangiola; Stefania Manfrida; Giovanna Mantini; Alessio Albanese; Alba Fiorentino; Vincenzo Frascino; Berardino De Bari; Francesco Micciche'; Fiorenza De Rose; Alessio Giuseppe Morganti; Carmelo Anile; Vincenzo Valentini
Journal:  Neuro Oncol       Date:  2011-10-12       Impact factor: 12.300

4.  Wild-type p53 enhances the cytotoxic effect of radionuclide gene therapy using sodium iodide symporter in a murine anaplastic thyroid cancer model.

Authors:  Yong Jin Lee; June-Key Chung; Joo Hyun Kang; Jae Min Jeong; Dong Soo Lee; Myung Chul Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-01       Impact factor: 9.236

5.  Down-regulation of Wilms' tumor 1 expression in glioblastoma cells increases radiosensitivity independently of p53.

Authors:  Aaron J Clark; Dana C Chan; Mike Y Chen; Helen Fillmore; Wagner G Dos Santos; Timothy E Van Meter; Martin R Graf; William C Broaddus
Journal:  J Neurooncol       Date:  2007-01-06       Impact factor: 4.506

6.  Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cells.

Authors:  Pei-Hsin Cheng; Serena Lian; Robin Zhao; Xiao-Mei Rao; Kelly M McMasters; Heshan Sam Zhou
Journal:  Virol J       Date:  2013-09-23       Impact factor: 4.099

7.  Applying a 4D multiscale in vivo tumor growth model to the exploration of radiotherapy scheduling: the effects of weekend treatment gaps and p53 gene status on the response of fast growing solid tumors.

Authors:  Dimitra D Dionysiou; Georgios S Stamatakos
Journal:  Cancer Inform       Date:  2007-02-16

8.  Gentian violet induces wtp53 transactivation in cancer cells.

Authors:  Alessia Garufi; Valerio D'Orazi; Jack L Arbiser; Gabriella D'Orazi
Journal:  Int J Oncol       Date:  2014-02-14       Impact factor: 5.650

9.  Zinc supplementation is required for the cytotoxic and immunogenic effects of chemotherapy in chemoresistant p53-functionally deficient cells.

Authors:  Mara Cirone; Alessia Garufi; Livia Di Renzo; Marisa Granato; Alberto Faggioni; Gabriella D'Orazi
Journal:  Oncoimmunology       Date:  2013-09-12       Impact factor: 8.110

Review 10.  Radioresistance of Brain Tumors.

Authors:  Kevin Kelley; Jonathan Knisely; Marc Symons; Rosamaria Ruggieri
Journal:  Cancers (Basel)       Date:  2016-03-30       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.